Cost-effectiveness.
Tuulonen
Anja
A
Azuara-Blanco
Augusto
A
D000959:Antihypertensive Agents / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D005902:Glaucoma, Open-Angle / Q000517:prevention & control; D017048:Health Care Costs; D006302:Health Services Research; D006801:Humans; D007348:Insurance, Health / Q000706:statistics & numerical data; D007429:Intraocular Pressure; D008390:Markov Chains; D009798:Ocular Hypertension / Q000191:economics* / Q000628:therapy*; D011788:Quality of Life; D019057:Quality-Adjusted Life Years; D012307:Risk Factors; D014130:Trabeculectomy / Q000191:economics; D014481:United States
D000959:Antihypertensive Agents